DE69839123D1 - Prostattumor polynukleotid- und antigenzusammensetzungen - Google Patents

Prostattumor polynukleotid- und antigenzusammensetzungen

Info

Publication number
DE69839123D1
DE69839123D1 DE69839123T DE69839123T DE69839123D1 DE 69839123 D1 DE69839123 D1 DE 69839123D1 DE 69839123 T DE69839123 T DE 69839123T DE 69839123 T DE69839123 T DE 69839123T DE 69839123 D1 DE69839123 D1 DE 69839123D1
Authority
DE
Germany
Prior art keywords
present
polypeptides
prostate tumor
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69839123T
Other languages
English (en)
Other versions
DE69839123T2 (de
Inventor
Reiner Laus
Michael H Shapero
Larisa Tsavaler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dendreon Corp
Original Assignee
Dendreon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dendreon Corp filed Critical Dendreon Corp
Publication of DE69839123D1 publication Critical patent/DE69839123D1/de
Application granted granted Critical
Publication of DE69839123T2 publication Critical patent/DE69839123T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69839123T 1997-08-20 1998-08-18 Prostattumor polynukleotid- und antigenzusammensetzungen Expired - Lifetime DE69839123T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5611097P 1997-08-20 1997-08-20
US56110P 1997-08-20
US09/112,096 US6194152B1 (en) 1997-08-20 1998-07-09 Prostate tumor polynucleotide compositions and methods of detection thereof
US112096 1998-07-09
PCT/US1998/017058 WO1999009166A2 (en) 1997-08-20 1998-08-18 Prostate tumor polynucleotide and antigen compositions

Publications (2)

Publication Number Publication Date
DE69839123D1 true DE69839123D1 (de) 2008-03-27
DE69839123T2 DE69839123T2 (de) 2009-02-05

Family

ID=26734980

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69839123T Expired - Lifetime DE69839123T2 (de) 1997-08-20 1998-08-18 Prostattumor polynukleotid- und antigenzusammensetzungen

Country Status (11)

Country Link
US (1) US6194152B1 (de)
EP (1) EP1005549B1 (de)
JP (1) JP4234319B2 (de)
AT (1) ATE386117T1 (de)
AU (1) AU744875B2 (de)
CA (1) CA2300364C (de)
DE (1) DE69839123T2 (de)
ES (1) ES2301208T3 (de)
HK (1) HK1029139A1 (de)
NZ (1) NZ503404A (de)
WO (1) WO1999009166A2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381407B1 (en) * 1996-03-25 2008-06-03 Medarex, Inc. Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
US6962981B1 (en) * 1996-03-25 2005-11-08 Medarex, Inc. Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
US6541212B2 (en) * 1997-03-10 2003-04-01 The Regents Of The University Of California Methods for detecting prostate stem cell antigen protein
DE19811193A1 (de) * 1998-03-10 1999-09-16 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Prostatatumorgewebe
US20040009478A1 (en) * 1998-03-10 2004-01-15 Metagen Gesellschaft Fur Genomforschung Mbh Human nucleic acid sequences from prostate tumor tissue
US20030166132A1 (en) * 1998-08-26 2003-09-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2000040614A2 (en) * 1998-12-30 2000-07-13 Beth Israel Deaconess Medical Center, Inc. Characterization of the soc/crac calcium channel protein family
US7063959B1 (en) 1998-12-30 2006-06-20 Beth Israel Deaconess Medical Center, Inc. Compositions of the SOC/CRAC calcium channel protein family
US20020048777A1 (en) 1999-12-06 2002-04-25 Shujath Ali Method of diagnosing monitoring, staging, imaging and treating prostate cancer
EP1272633B1 (de) * 2000-03-30 2011-04-27 Dendreon Corporation Zusammensetzungen und verfahren für eine auf dendritischen zellen basierende immuntherapie
CA2417671A1 (en) * 2000-07-28 2002-02-07 Ulrich Wissenbach Trp8, trp9 and trp10, novel markers for cancer
JP4520631B2 (ja) * 2000-11-22 2010-08-11 松本油脂製薬株式会社 耐久透水性付与剤及びその繊維
US7115414B2 (en) * 2001-06-13 2006-10-03 IRM LLC, A Delaware Corp. Vanilloid receptor-related nucleic acids and polypeptides
US20050272120A1 (en) 2001-06-20 2005-12-08 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
CA2633171C (en) 2001-06-20 2012-11-20 Genentech, Inc. Antibodies against tumor-associated antigenic target (tat) polypeptides
US7371841B2 (en) 2002-01-25 2008-05-13 Regents Of The University Of California Methods of modulating cold sensory perception
DE10215321A1 (de) * 2002-04-02 2003-10-23 Metagen Pharmaceuticals Gmbh Trp-p8 Splice Varianten und regulatorische RNA
WO2003106616A2 (en) * 2002-06-12 2003-12-24 Gavish-Galilee Bio Applications Ltd MEMBRANE-ANCHORED β2 MICROGLOBULIN COVALENTLY LINKED TO MHC CLASS I PEPTIDE EPITOPES
US20080286312A1 (en) * 2002-06-12 2008-11-20 Gavish-Galilee Bio Applications Ltd. Membrane-anchored beta2 microglobulincovalently linked to MHC class I peptide epitopes
US20040092807A1 (en) * 2002-11-07 2004-05-13 Amos Breskin System and method for cancer detection
DE10259619A1 (de) * 2002-12-18 2004-07-08 Metagen Pharmaceuticals Gmbh Verwendung einer TRPM8 aktivierenden Substanz zur Tumorbehandlung
US6893626B2 (en) * 2003-02-18 2005-05-17 Edward T. Wei Compositions for TRP-M8 binding and radioreceptor methods therewith
EP1675956B1 (de) * 2003-10-21 2010-10-13 Merck Serono SA Minimale dna sequenz, die als chromatin-isolator wirkt, und deren verwendung für die protein-expression
GB0407175D0 (en) * 2004-03-30 2004-05-05 Paradigm Therapeutics Ltd Ion channel
CN101124249B (zh) * 2005-02-18 2011-06-29 米德列斯公司 抗前列腺特异性膜抗原（psma）的人单克隆抗体
US7875278B2 (en) * 2005-02-18 2011-01-25 Medarex, Inc. Monoclonal antibodies against prostate specific membrane antigen (PSMA) lacking in fucosyl residues
GB201021499D0 (en) * 2010-12-20 2011-02-02 Loxbridge Res Llp Detection of quantative genetic differnces
US10022402B2 (en) 2012-12-03 2018-07-17 Subhadra Dravida Allogenic mesendritic vector for ovarian cancer
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1757694A3 (de) 1992-11-05 2008-02-27 Sloan Kettering Institute For Cancer Research Prostata-spezifisches Membranantigen
US5599677A (en) 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
WO1995030758A1 (en) 1994-05-10 1995-11-16 Mayo Foundation For Medical Education And Research Recombinant hk2 polypeptide
US5614372A (en) 1995-02-24 1997-03-25 Lilja; Hans Early detection of prostate cancer (CAP) by employing prostate specific antigen (PSA) and human glandular kallikrein (hGK-1)
US5633161A (en) 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US5830649A (en) * 1995-05-26 1998-11-03 Smithkline Beecham Corporation Human galactokinase gene
US5710007A (en) 1995-09-29 1998-01-20 Luderer; Albert A. Methods for diagnosing prostatic adenocarcinoma

Also Published As

Publication number Publication date
EP1005549A2 (de) 2000-06-07
US6194152B1 (en) 2001-02-27
WO1999009166A2 (en) 1999-02-25
ATE386117T1 (de) 2008-03-15
CA2300364A1 (en) 1999-02-25
EP1005549B1 (de) 2008-02-13
HK1029139A1 (en) 2001-03-23
ES2301208T3 (es) 2008-06-16
WO1999009166A3 (en) 1999-06-03
DE69839123T2 (de) 2009-02-05
JP2001514889A (ja) 2001-09-18
AU744875B2 (en) 2002-03-07
NZ503404A (en) 2002-03-01
JP4234319B2 (ja) 2009-03-04
CA2300364C (en) 2014-06-10
AU9021898A (en) 1999-03-08

Similar Documents

Publication Publication Date Title
ATE386117T1 (de) Prostattumor polynukleotid- und antigenzusammensetzungen
WO2001055447A8 (en) Nucleic acids, proteins, and antibodies
PT991421E (pt) Deteccao e modulacao das iap e naip para o diagnostico e tratamento de doenca proliferativa
DE60136099D1 (de) Zusammensetzungen zur behandlung und diagnose von eierstockkrebs
EA200400179A1 (ru) Лечение и диагностика рака
DE60228997D1 (de) Zusammensetzungen und verfahren zur diagnose und behandlung eines tumors
TR200200937T2 (tr) Yumurtalık kanseri tedavisi için bileşimler.
DE69717664D1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
ATE266203T1 (de) Methode zur identifizierung von tumorantigenen mit autoantikörpern in serum
ATE449171T1 (de) Reagentia und verfahren zum nachweis von brustkrankheiten
ATE291738T1 (de) Diagnose und behandlung von krebs unter verwendung von sgp28-ähnlichen molekülen
WO2000007545A3 (en) Apoptosis proteins
DE69531167D1 (de) Verfahren zum nachweis und therapie von schuppenartigen zellkarzinomen und blasen-karzinomen insbesondere zur bestimmung der anwesenheit und behandlung von minimalen resterkrankungen, micrometastasierung oder der verbreitung von solchen karzinomtypen
ATE329027T1 (de) Menschliches leucinereiche wiederholungen enthaltendes protein, vorwiegend im dünndarm exprimiert, hlrrsi1
WO2001055313A3 (en) Nucleic acids, proteins, and antibodies
EP1243653A3 (de) E25a Protein, Methoden zur Herstellung und Verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition